Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Anti-Metastatic and Anti-Tumorigenic Effects in Endometrial Cancer
Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2014.05.015
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2014
Authors
Publisher
Elsevier BV